Public consultation regarding the implementation of the Second European and Developing Countries Clinical Trials Partnership Programme (EDCTP2) during the period 2014-2016.
|Research & Technological Development.|
|All citizens and organisations are welcome to contribute. However, contributions from stakeholders and experts active in the field of clinical trials in developing countries are particularly sought after.|
|Period of consultation|
|From 29/06/2016 to 15/11/2016.|
|Objective of the consultation|
|The purpose of this consultation is to invite the views and opinions of stakeholders, experts active in the field and the wider public on the implementation of the EDCTP2 Programme during the first three years of operation (2014-2016). These views and opinions will contribute to the interim evaluation of the EDCTP2 programme, carried out by the European Commission with the assistance of independent experts. The objective of the interim evaluation is to assess the implementation of the EDCTP2 programme up to the present moment; to judge how recommendations from previous evaluations have been implemented; and to provide an outlook on what can be expected from EDCTP2 in the future.|
|How to submit your contribution|
|Please click here to submit your contribution. Contributions will be published on the Internet. For more information on how your personal data and contribution will be dealt with, please read the specific privacy statement attached to this consultation.|
|View the consultation documents|
Before completing the questionnaire, you may wish to take a look at EU decision on the participation of the Union in a second European and Developing Countries Clinical Trials partnership programme jointly undertaken by several Member States.You may also wish to see the report of the independent external evaluation and the results of the public consultation on the first EDCTP programme ( 800 KB) and the EDCTP website.
|View the questionnaire|
|It should take about 15 minutes to complete the questionnaire, depending on how detailed your answers are. You can, however, preview/print a PDF version of the online questionnaire ( 60 KB) here to help you to prepare your response.|
|European Commission, Directorate-General for Research and Innovation, Unit RTD E3: Fighting infectious diseases and advancing public health|
View the contributions
In the interests of transparency, organisations are invited to provide the public with relevant information about themselves by registering in the Interest Representative Register and subscribing to its Code of Conduct. If the organisation is not registered, the submission is published separately from the registered organisations.
|Results of consultation and next steps|